Skip to content

Joel Sangerman

Joel Sangerman

Company: Click Therapeutics

Job title: Chief Commercial Officer

Seminars:

Q&A Session with the Expert Speakers 11:30 am

Key topics to be discussed include: • Understanding the current approach of clinicians to digital therapeutics and the current limitations faced in DTx applications • Discussing the differing privacy and cybersecurity levels across healthcare organizations • Integrating digital therapeutics to the complex workflows existing in healthcare systems, from clinical dashboards and patient activation to prescription…Read more

day: Day Two

Chair’s Opening Remarks 8:50 am

Read more

day: Day Two

Q&A Session with the Expert Speakers 4:30 pm

• Understanding evidence requirements of public vs private insurers • Clarifying the reimbursement categories within the US market, from drug to psychosocial services, and their impact on DTx development and commercialization • Developing direct to consumer models: Comparing prescribable to over-the-counter routes for consumer accessibility • Exploring recent guidelines issued by NICE and Germany, and…Read more

day: Day One

Digital Therapeutics: Software as Prescription Medical Treatments 1:30 pm

• Hear what healthcare executives need to know and what is being missed • Learn how prescription digital therapeutics (PDTs) will be integrated in to care protocols • Understand how reimbursement, medical policies, and drug formularies will change as PDTs enter the marketRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.